Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenta Okada

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Endocrine Journal|April 12, 2013
Effects of miglitol versus sitagliptin on postprandial glucose and lipoprotein metabolism in patients with type 2 diabetes mellitusKenta Okada, Hiroaki Yagyu, Kazuhiko Kotani, et al.
The FEBS Journal|May 3, 2019
Novel lineage-specific transmembrane β-barrel proteins in the endoplasmic reticulum of Entamoeba histolyticaHerbert J Santos, Kenichiro Imai, Takashi Makiuchi, et al.
Journal of Lipid Research|February 5, 2013
Macrophage lipoprotein lipase modulates the development of atherosclerosis but not adiposityManabu Takahashi, Hiroaki Yagyu, Fumiko Tazoe, et al.
Diabetes Research and Clinical Practice|May 11, 2010
Distinct association of serum FGF21 or adiponectin levels with clinical parameters in patients with type 2 diabetesKazuhiro Eto, Bayasgalan Tumenbayar, Shu-ichi Nagashima, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 16, 2012
Liver-specific deletion of 3-hydroxy-3-methylglutaryl coenzyme A reductase causes hepatic steatosis and deathShuichi Nagashima, Hiroaki Yagyu, Ken Ohashi, et al.
Medicine|September 1, 2023
Association of plasminogen activator inhibitor-1 and fibroblastic growth factor 21 in 3 groups of type 2 diabetes: Without overweight/obesity, free of insulin resistance, and without hepatosteatosisNoriko Takebe, Yutaka Hasegawa, Yuriko Matsushita, et al.
Journal of Atherosclerosis and Thrombosis|May 21, 2011
Molecular analysis of a novel LCAT mutation (Gly179 → Arg) found in a patient with complete LCAT deficiencyXiao Li Wang, Jun-ichi Osuga, Fumiko Tazoe, et al.
Journal of Diabetes Investigation|September 4, 2021
Comparison of the effects of frequent versus conventional nutritional interventions in patients with type 2 diabetes mellitus: A randomized, controlled trialNao Kawabata, Kenta Okada, Akihiko Ando, et al.
Endocrine Journal|March 8, 2023
A case of vasoactive intestinal peptide-secreting tumor (VIPoma) arising from MEN1 inactivation which recurred 15 years after the initial resectionMomoe Sakurai, Tetsuji Wakabayashi, Yasuyuki Kondo, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|August 19, 2020
Effects of luseogliflozin on arterial properties in patients with type 2 diabetes mellitus: The multicenter, exploratory LUSCAR studyKazuomi Kario, Kenta Okada, Mitsunobu Murata, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Endocrine Journal|April 12, 2013
Effects of miglitol versus sitagliptin on postprandial glucose and lipoprotein metabolism in patients with type 2 diabetes mellitusKenta Okada, Hiroaki Yagyu, Kazuhiko Kotani, et al.
The FEBS Journal|May 3, 2019
Novel lineage-specific transmembrane β-barrel proteins in the endoplasmic reticulum of Entamoeba histolyticaHerbert J Santos, Kenichiro Imai, Takashi Makiuchi, et al.
Journal of Lipid Research|February 5, 2013
Macrophage lipoprotein lipase modulates the development of atherosclerosis but not adiposityManabu Takahashi, Hiroaki Yagyu, Fumiko Tazoe, et al.
Diabetes Research and Clinical Practice|May 11, 2010
Distinct association of serum FGF21 or adiponectin levels with clinical parameters in patients with type 2 diabetesKazuhiro Eto, Bayasgalan Tumenbayar, Shu-ichi Nagashima, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 16, 2012
Liver-specific deletion of 3-hydroxy-3-methylglutaryl coenzyme A reductase causes hepatic steatosis and deathShuichi Nagashima, Hiroaki Yagyu, Ken Ohashi, et al.
Medicine|September 1, 2023
Association of plasminogen activator inhibitor-1 and fibroblastic growth factor 21 in 3 groups of type 2 diabetes: Without overweight/obesity, free of insulin resistance, and without hepatosteatosisNoriko Takebe, Yutaka Hasegawa, Yuriko Matsushita, et al.
Journal of Atherosclerosis and Thrombosis|May 21, 2011
Molecular analysis of a novel LCAT mutation (Gly179 → Arg) found in a patient with complete LCAT deficiencyXiao Li Wang, Jun-ichi Osuga, Fumiko Tazoe, et al.
Journal of Diabetes Investigation|September 4, 2021
Comparison of the effects of frequent versus conventional nutritional interventions in patients with type 2 diabetes mellitus: A randomized, controlled trialNao Kawabata, Kenta Okada, Akihiko Ando, et al.
Endocrine Journal|March 8, 2023
A case of vasoactive intestinal peptide-secreting tumor (VIPoma) arising from MEN1 inactivation which recurred 15 years after the initial resectionMomoe Sakurai, Tetsuji Wakabayashi, Yasuyuki Kondo, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|August 19, 2020
Effects of luseogliflozin on arterial properties in patients with type 2 diabetes mellitus: The multicenter, exploratory LUSCAR studyKazuomi Kario, Kenta Okada, Mitsunobu Murata, et al.
Pageof 5